Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...
November 6, 2024Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $1.37, expectations were $0.14.
Emergent Biosolutions ( (EBS) ) has released its Q3 earnings. Here is a breakdown of the information Emergent Biosolutions presented to its ...
Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase and significant debt reduction, despite challenges in Narcan sales.
Emergent BioSolutions (EBS) is up 36.1%, or $3.32 to $12.52. Published first on TheFly – the ultimate source for real-time, ...
Thursday after the company reported strong third-quarter results, lifting retail sentiment. Earnings per share for Q3 came in ...
The U.S. overdose crisis and its racial disparities were overlooked in the election, as Black and Indigenous Americans face rising death rates.
Wiles is co-chair at lobbying firm Mercury Public Affairs and has represented clients in the tobacco, junk food, insurance, ...
Emergent BioSolutions Inc. is heading into its next chapter — or “turnaround” phase, as its CEO describes it — after a strong ...
On Thursday, Emergent Biosolutions Inc (EBS) stock saw a modest uptick, ending the day at $11 which represents a slight increase of $1.80 or 19.57% from the prior close of $9.2. The stock opened at ...
Amazon is reportedly discussing an additional multi-billion dollar investment in artificial intelligence startup Anthropic, ...
Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...